Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 1998, p. 2569-2575, Vol. 42, No. 10
Institute of Medical Microbiology and
Hygiene,
Received 30 March 1998/Returned for modification 1 July
1998/Accepted 3 August 1998
A cytofluorometric assay that allowed assessment of damage to
phagocytosed Aspergillus fumigatus conidia at the
single-cell level was developed. After ingestion by monocyte-derived
macrophages (MDMs), conidia were reisolated by treatment of the
cells with streptolysin O, a pore-forming toxin with lytic properties
on mammalian cells but not on fungi. The counts obtained by staining of
damaged conidia with propidium iodide and quantification by cytofluorometry correlated with colony counts. By the use of this method, we demonstrate that MDMs differentiated in vitro by low-dose granulocyte-macrophage colony-stimulating factor and gamma
interferon have only a limited capacity to damage
Aspergillus conidia in vitro. The killing rate 12 h
after phagocytosis was found to be only 10 to 15%. However,
intracellular loading of the phagocytes with amphotericin B (AmB) dose
dependently enhanced the anticonidial activity. Preincubation of
macrophages with only 1 µg of AmB per ml resulted in an
uptake of 18 fg of AmB/cell, leading to killing rates of 50 to 60%.
The experimental protocol provides a new tool for the rapid
quantification of anticonidial activity against A. fumigatus in vitro. Intracellular accumulation of AmB may
represent an important factor underlying the efficacy of this
antifungal drug in the prophylaxis and treatment of
Aspergillus infections.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Accumulation of Amphotericin B in Human Macrophages Enhances
Activity against Aspergillus fumigatus Conidia:
Quantification of Conidial Kill at the Single-Cell Level
*
Corresponding author. Mailing address: Institute of
Medical Microbiology and Hygiene, Hochhaus am Augustusplatz, D-55101
Mainz, Germany. Phone: 49-6131-172865. Fax: 49-6131-392359. E-mail:
bjahn{at}mzdmza.zdv.uni-mainz.de.
Antimicrobial Agents and Chemotherapy, October 1998, p. 2569-2575, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |